Abbott Laboratories vs. Akari Therapeutics plc ADR (0.01 USD)
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | AKTX | |
|---|---|---|
| Market Cap | $185.75 billion | $14.88 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | AKTX | |
|---|---|---|
| Dividend Yield | 2.35% | — |
ABT and AKTX split the dividend factors evenly.
Risk & Sentiment
| ABT | AKTX | |
|---|---|---|
| Short Interest | 0.57% | 25.74% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, AKTX overview, AKTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.